Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases. Read more about Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases.
The C-terminal extension landscape of naturally presented HLA-I ligands. Read more about The C-terminal extension landscape of naturally presented HLA-I ligands.
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma. Read more about TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma.
Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype. Read more about Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors. Read more about Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors.
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth. Read more about Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth.
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models. Read more about DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.
BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability. Read more about BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability.
1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors. Read more about 1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.
